Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatitis: Hepatitis E vaccination--is HEV 239 the breakthrough?

Literature DB >> 21212772

Hepatitis: Hepatitis E vaccination--is HEV 239 the breakthrough?

Heiner Wedemeyer, Sven Pischke.

Abstract

Entities: Disease

Mesh：

Substances：
Viral Hepatitis Vaccines

Year: 2011 PMID： 21212772 DOI： 10.1038/nrgastro.2010.207

Source DB: PubMed Journal: Nat Rev Gastroenterol Hepatol ISSN： 1759-5045 Impact factor: 46.802

× No keyword cloud information.

9 in total

1. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.

Authors: Feng-Cai Zhu; Jun Zhang; Xue-Feng Zhang; Cheng Zhou; Zhong-Ze Wang; Shou-Jie Huang; Hua Wang; Chang-Lin Yang; Han-Min Jiang; Jia-Ping Cai; Yi-Jun Wang; Xing Ai; Yue-Mei Hu; Quan Tang; Xin Yao; Qiang Yan; Yang-Ling Xian; Ting Wu; Yi-Min Li; Ji Miao; Mun-Hon Ng; James Wai-Kuo Shih; Ning-Shao Xia
Journal: Lancet Date: 2010-08-20 Impact factor: 79.321

2. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.

Authors: Yellapu Radha Krishna; Vivek Anand Saraswat; Khaunish Das; Goel Himanshu; Surender Kumar Yachha; Rakesh Aggarwal; Gour Choudhuri
Journal: Liver Int Date: 2009-03 Impact factor: 5.828

Review 3. Chronic hepatitis E in liver transplant recipients: a significant clinical problem?

Authors: S Pischke; H Wedemeyer
Journal: Minerva Gastroenterol Dietol Date: 2010-06

4. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.

Authors: Nassim Kamar; Lionel Rostaing; Florence Abravanel; Cyril Garrouste; Sebastien Lhomme; Laure Esposito; Grégoire Basse; Olivier Cointault; David Ribes; Marie Béatrice Nogier; Laurent Alric; Jean Marie Peron; Jacques Izopet
Journal: Gastroenterology Date: 2010-08-11 Impact factor: 22.682

5. Safety and efficacy of a recombinant hepatitis E vaccine.

Authors: Mrigendra Prasad Shrestha; Robert McNair Scott; Durga Man Joshi; Mammen P Mammen; Gyan Bahadur Thapa; Narbada Thapa; Khin Saw Aye Myint; Marc Fourneau; Robert A Kuschner; Sanjaya Kumar Shrestha; Marie Pierre David; Jitvimol Seriwatana; David W Vaughn; Assad Safary; Timothy P Endy; Bruce L Innis
Journal: N Engl J Med Date: 2007-03-01 Impact factor: 91.245

Review 6. Hepatitis E and pregnancy: understanding the pathogenesis.

Authors: Udayakumar Navaneethan; Mayar Al Mohajer; Mohamed T Shata
Journal: Liver Int Date: 2008-07-25 Impact factor: 5.828

7. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.

Authors: Sven Pischke; Pothakamuri V Suneetha; Christine Baechlein; Hannelore Barg-Hock; Albert Heim; Nassim Kamar; Jerome Schlue; Christian P Strassburg; Frank Lehner; Regina Raupach; Birgit Bremer; Peter Magerstedt; Markus Cornberg; Frauke Seehusen; Wolfgang Baumgaertner; Juergen Klempnauer; Jacques Izopet; Michael P Manns; B Grummer; Heiner Wedemeyer
Journal: Liver Transpl Date: 2010-01 Impact factor: 5.799

Review 8. Hepatitis E: an emerging awareness of an old disease.

Authors: R H Purcell; S U Emerson
Journal: J Hepatol Date: 2008-01-02 Impact factor: 25.083

9. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine.

Authors: Jun Zhang; Chong-Bo Liu; Rong-Cheng Li; Yi-Min Li; Ying-Jie Zheng; Yan-Ping Li; Dong Luo; Bai-Bin Pan; Yi Nong; Sheng-Xiang Ge; Jun-Hui Xiong; James Wai-Kuo Shih; Mun-Hon Ng; Ning-Shao Xia
Journal: Vaccine Date: 2009-01-23 Impact factor: 3.641

9 in total

4 in total

Review 1. Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment.

Authors: Nassim Kamar; Sven Pischke
Journal: Cold Spring Harb Perspect Med Date: 2019-07-01 Impact factor: 6.915